Navigation Links
K-V Pharmaceutical Names Thomas McHugh Chief Financial Officer
Date:7/15/2010

ST. LOUIS, July 15 /PRNewswire-FirstCall/ -- K-V Pharmaceutical Company (NYSE:  KVa/KVb) announced today that Thomas S. McHugh has been appointed Chief Financial Officer, effective immediately.

Mr. McHugh joined K-V in January 2009 as Vice President of Finance and Corporate Controller.  He served as the company's Interim Chief Financial Officer from September 2009 until April 2010 and as the Chief Accounting Officer since February 2010.  He possesses over 20 years of financial management expertise in the areas of regulatory and government compliance, internal and external financial reporting, investor relations, mergers and acquisitions and global finance.  

Greg Divis, Interim Chief Executive Officer of K-V, stated, "Tom has played a key leadership role on our finance team at a time when sound management of our financial resources and return to compliance has never been more vital.  His assumption of the role of CFO will further strengthen our financial management and help K-V as we continue to prepare for the resumption of normal business operations. We believe that Tom will continue to make a positive impact going forward and look forward to his contributions."

Prior to joining K-V, Mr. McHugh was the Managing Director – Global and Corporate Controller with Bearing Point, Inc. from 2005 to 2008; Vice President of Finance, Chief Financial Officer, Treasurer and Chief Accounting Officer with Huttig Building Products, Inc. from 2000 to 2005; and Corporate Controller and Chief Accounting Officer with XTRA Corporation from 1993 to 2000.  Mr. McHugh began his professional career
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... HILL, N.C. , Aug. 22, 2014  Medical ... organizations and thought leaders in the healthcare sector. As ... evolve, the iPad is changing how Medical Science Liaisons ... MSLs are using the tablet to not ... but also to better coordinate thought leader interactions across ...
(Date:8/22/2014)... , August 22, 2014 ... http://www.researchandmarkets.com/research/x34qgv/global_laboratory ) has announced the addition of ...  report to their offering.       ... an essential instrument for any modern science ... weighing of materials. It can be broadly ...
(Date:8/22/2014)... , August 22, 2014 ... has announced the addition of the  "Global ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... with a sterile environment in a healthcare ... is equipped with technically advanced equipment, which ...
Breaking Medicine Technology:iPads Enhancing Medical Science Liaison Interactions with Thought Leaders, New Study Shows 2Global Laboratory Electronic Balance Market 2014-2018: Key Vendors are A&D Company, Mettler-Toledo, Sartorius and Thermo Fisher 2Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2
(Date:8/22/2014)... 22, 2014 The regional economy is ... is on the grow again. The plant ... summer 2016 to boost production of the popular Highlander ... Indiana’s overall investment to $4 billion. This step allows ... providing additional flexibility to adjust its product mix to ...
(Date:8/22/2014)... 2014 As the controversy surrounding ... in uterine surgeries continues to grow, Bernstein Liebhard ... decided to limit coverage of uterine morcellation. According ... Cross-Blue Shield of Massachusetts will no longer cover ... as of September 1, 2014. Other insurers in ...
(Date:8/22/2014)... (BIM) deletion in advanced non-small cell lung cancer ... (PFS) in epidermal growth factor receptor (EGFR) tyrosine ... Also, BIM deletion independently predicts overall survival (OS) ... can activate the programmed cell death also known ... has been detected in 12.8% of the Asian ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Restore ... Sen and Dr. Samantha Pearson to help people discover ... avoid corrective vision surgery by instead improving their eyesight ... an investigative review. , “There’s a reason why ... in revenue each year—it’s because people just assume that ...
(Date:8/22/2014)... County, NJ (PRWEB) August 22, 2014 ... a leading specialist in Internal Medicine, Geriatrics, Hospice ... the network, CarePoint Health Medical Group. Their system ... highly skilled and experienced physicians comprise CarePoint Health ... and practices in Hudson County, representing a wide ...
Breaking Medicine News(10 mins):Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 3Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 4Health News:Deletion predicts survival in advanced non-small cell lung cancer 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Dr. Reisner Joins CarePoint Health Medical Group 2
... Army immediately introduce yoga for its soldiers in field ... need for regular lectures and exercises on yoga techniques ... may be initiated in this direction," the standing committee ... and education in the defence sector" tabled in both ...
... conducted in India by Johns Hopkins Bloomberg School of Public ... of early death// for their children. The risk of death ... for children of mothers who were subjected to harassment. ... the American Journal of Public Health. ,“Our findings indicate ...
... worsening chest pain or a certain type of heart ... treatment// rather than being treated conservatively, a new review ... suggests that an early invasive strategy is superior to ... the Centre for Research in Vascular Biology at the ...
... A one-year-old Pakistani boy has undergone a successful liver transplant ... recipient in India// , said doctors here Wednesday. ,Shreyar, ... surgery on June 19 at the Sir Ganga Ram Hospital ... private hospital said. ,"Shreyar is now completely ...
... cancer surgery may play a crucial role in whether the ... in the August 1, 2006, issue of the International Journal ... of ASTRO, the American Society for Therapeutic Radiology and Oncology. ... learn they have breast cancer. Many women with early stage ...
... doctor away, yes; but researchers say it could also ... apple juice were found to boost brain activity in ... the University of Massachusetts Lowell (UML). The animal research ... in the brain of the essential neurotransmitter acetylcholine. This ...
Cached Medicine News:Health News:Yoga to De-stress Indian Army Soldiers 2Health News:Risk Of Death Increased In Children Of Mothers Subjected To Domestic Violence 2Health News:Emergency Heart Patients Do Better With Invasive Approach 2Health News:Emergency Heart Patients Do Better With Invasive Approach 3Health News:Emergency Heart Patients Do Better With Invasive Approach 4Health News:Pakistani Child is India's Youngest Liver Transplant Recipient 2Health News:Leftover Cancer Cells May Dictate Breast Cancer Relapse 2Health News:Apple Juice May Keep Alzheimer's Away 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: